In Brief: Bayer Cipro
Executive Summary
Bayer Cipro: Ciprofloxacin I.V. approved Oct. 21 for the additional indication of treatment of nosocomial pneumonia caused by Haemophilus influenzae and Klebsiella pneumoniae. Cipro solution and tablets approved for use in combination with metronidazole for complicated intra-abdominal infections caused by mixed aerobic/anaerobic pathogens on Oct. 10. Cipro was approved for bacterial prostatitis in September ("The Pink Sheet" Sept. 30, In Brief)...